KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Non Operating Income: 2009-2024

Historic Non Operating Income for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to -$14.0 million.

  • Nektar Therapeutics' Non Operating Income fell 23.90% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.7 million, marking a year-over-year decrease of 2.89%. This contributed to the annual value of -$14.0 million for FY2024, which is 11.37% down from last year.
  • Latest data reveals that Nektar Therapeutics reported Non Operating Income of -$14.0 million as of FY2024, which was down 11.37% from -$12.6 million recorded in FY2023.
  • Nektar Therapeutics' 5-year Non Operating Income high stood at $11.2 million for FY2022, and its period low was -$77.2 million during FY2021.
  • In the last 3 years, Nektar Therapeutics' Non Operating Income had a median value of -$12.6 million in 2023 and averaged -$5.1 million.
  • In the last 5 years, Nektar Therapeutics' Non Operating Income slumped by 309.73% in 2021 and then soared by 114.49% in 2022.
  • Nektar Therapeutics' Non Operating Income (Yearly) stood at -$18.8 million in 2020, then plummeted by 309.73% to -$77.2 million in 2021, then soared by 114.49% to $11.2 million in 2022, then crashed by 212.42% to -$12.6 million in 2023, then dropped by 11.37% to -$14.0 million in 2024.